Osiris Therapeutics
Country
USA
Краткое название
Osiris Therapeutics
Headquarters
7015 Albert Einstein Drive
Members of the board
C. Randal Mills, Ph.D.,
President and Chief Executive Officer
Philip R. Jacoby, Jr.,
Chief Financial Officer and Corporate Secretary
Michelle LeRoux Williams, Ph.D.,
Chief Scientific Officer
Lode Debrabandere, Ph.D.,
Chief Operating Officer
Christopher R. Alder, J.D.,
Chief Intellectual Property Counsel
Categories medicine
Cardiology, Infectious diseases, Orthopedics
Stage of the project
Production
Disease
Arthrosis, HIV, Viral hepatitis, Ischemic heart disease
Ticker
OSIR
Current owners
Peter Friedli,
Chairman
C. Randal Mills, Ph.D.,
President and Chief Executive Officer
Felix Gutzwiller, M.D., Dr.P.H.,
Jay M. Moyes,
Hans Klingemann, M.D., Ph.D.
Assets
671.9800
Technology
Other, Cell Technologies, Devices, Technologies, Pharmaceuticals, Chemistry